MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in c...
Leadership
Vlad Vitoc M.B.A., M.D.Founder
Co-Founder, President, CEO & Chairman of the Board of Directors
Jeffrey C. Himmelreich M.B.A.
Head of Finance and Principal Financial & Accounting Officer
